chloroquine and propranolol

chloroquine has been researched along with propranolol in 51 studies

Research

Studies (51)

Timeframe	Studies, this research(%)	All Research%
pre-1990	16 (31.37)	18.7374
1990's	5 (9.80)	18.2507
2000's	11 (21.57)	29.6817
2010's	17 (33.33)	24.3611
2020's	2 (3.92)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA	1
Fitos, I; Mády, G; Visy, J; Zsila, F	1
Lombardo, F; Obach, RS; Waters, NJ	1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Ahman, M; Holmén, AG; Wan, H	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Buckley, DB; Funk, RS; Hensley, T; Kazmi, F; Loewen, GJ; Parkinson, A; Pope, C	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Chibale, K; Egan, TJ; Hunter, R; Joshi, MC; Ndove, J; Nsumiwa, S; Okombo, J; Taylor, D; Wiesner, L	1
Bavari, S; Besch, R; Duplantier, AJ; Jay, WB; Kota, KP; Kuehl, K; Lazić, M; Mudhasani, R; Panchal, RG; Pavić, A; Retterer, C; Sean, VA; Selaković, Ž; Šolaja, BA; Soloveva, V; Tran, JP; Vasiljević, B; Verbić, T	1
Ally, AI; Cunnane, SC; Horrobin, DF; Karmali, RA; Karmazyn, M; Manku, MS; Morgan, RO; Oka, M	1
Baron, PL; Meola, G; Moggio, M; Santilli, I; Scarlato, G; Scarpini, E	1
Ontko, JA; Woodside, WF	1
Bazan, NG; Van Rooijen, LA	1
Cramb, G	1
Fabisiak, JP; Rannels, DE; Rannels, SR; Vesell, ES	1
Curtis, DH; Entwistle, A; Zalin, RJ	1
Coudert, B; Dwyer, TM; Joshi, UM; Kodavanti, PR; Mehendale, HM	1
Bazan, NG; Reddy, TS	1
Hostetler, KY; Kubo, M	1
Dinnendahl, V; Peters, HD; Schönhöfer, PS	1
Hawkins, D	1
Abdel-Aziz, A; Bakry, N	1
Meerson, FZ; Pshennikova, MG; Rysmendiev, AZh; Vorontsova, EIa	1
Sofola, OA	1
Nedostup, AV	1
Ohkuma, S; Poole, B	1
Mak, IT; Stafford, R; Weglicki, WB	1
Goos, M; Mertins, K; Nussbaum, G; Ockenfels, HM; Schultewolter, T; Wagner, SN	1
Jancinová, V; Májeková, M; Nosál, R; Petríková, M	1
García-Sáinz, JA; Mendoza-Mendoza, A	1
Jancinová, V; Nosál, R	1
Cen, JP; Cheng, H; Jin, N; Lin, AH; Zhu, KJ	1
Hagström, M; Kidron, H; Rimpelä, AK; Urtti, A	1
Hagström, M; Hellinen, L; Knuutila, H; Reinisalo, M; Ruponen, M; Urtti, A	1
Anselmino, LE; Baglioni, MV; Menacho-Márquez, M; Reynoso, G; Rico, MJ; Rozados, VR; Scharovsky, OG	1
Cavalcanti, JVFL; da Motta Sobrinho, MA; de Araújo, CMB; Del Carmen Pinto Osorio, D; do Nascimento, BF; Dotto, GL; Silva, LFO	1

Reviews

1 review(s) available for chloroquine and propranolol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

50 other study(ies) available for chloroquine and propranolol

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Rational use of in vitro P-glycoprotein assays in drug discovery. The Journal of pharmacology and experimental therapeutics, 2001, Volume: 299, Issue:2 Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera	2001
Selective plasma protein binding of antimalarial drugs to alpha1-acid glycoprotein. Bioorganic & medicinal chemistry, 2008, Apr-01, Volume: 16, Issue:7 Topics: Antimalarials; Binding Sites; Chromatography, Affinity; Circular Dichroism; Humans; Molecular Structure; Orosomucoid; Protein Binding; Serum Albumin; Spectrophotometry; Stereoisomerism; Structure-Activity Relationship	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship	2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets. Journal of medicinal chemistry, 2012, Jan-12, Volume: 55, Issue:1 Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics	2012
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells). Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:4 Topics: Adrenergic beta-Antagonists; Amines; Ammonium Chloride; Antidepressive Agents, Tricyclic; Atorvastatin; Cell Line, Transformed; Diuretics; Hepatocytes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imipramine; Lysosomes; Monensin; Nigericin; Propranolol; Pyrroles	2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
4-Aminoquinoline Antimalarials Containing a Benzylmethylpyridylmethylamine Group Are Active against Drug Resistant Plasmodium falciparum and Exhibit Oral Activity in Mice. Journal of medicinal chemistry, 2017, 12-28, Volume: 60, Issue:24 Topics: Administration, Oral; Aminopyridines; Aminoquinolines; Animals; Antimalarials; Cell Membrane Permeability; Chloroquine; CHO Cells; Cricetulus; Drug Evaluation, Preclinical; Drug Resistance, Microbial; ERG1 Potassium Channel; Hemeproteins; Humans; Malaria; Male; Mice, Inbred BALB C; Plasmodium berghei; Plasmodium falciparum; Solubility; Structure-Activity Relationship	2017
Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action. European journal of medicinal chemistry, 2019, Jan-15, Volume: 162 Topics: Animals; Antiviral Agents; Chrysenes; Ebolavirus; Hemorrhagic Fever, Ebola; Lysosomes; Mice; Surface-Active Agents; Virus Internalization; Zebrafish	2019
Changes in coronary vascular resistance associated with prolonged hypoxia in isolated rat hearts: a possible role of prostaglandins. Life sciences, 1979, Dec-03, Volume: 25, Issue:23 Topics: Aging; Animals; Aspirin; Chloroquine; Coronary Circulation; Coronary Disease; In Vitro Techniques; Indomethacin; Male; Procaine; Propranolol; Prostaglandins; Rats; Time Factors; Vascular Resistance	1979
Lysosomotropic agents induce morphological and functional changes in human muscle cells in vitro. European journal of basic and applied histochemistry, 1991, Volume: 35, Issue:4 Topics: Cells, Cultured; Chloroquine; Histocytochemistry; Humans; Leupeptins; Lysosomes; Microscopy, Electron; Muscles; Propranolol	1991
Regulation of triglyceride mobilization in isolated hepatocytes by dibutyryl cyclic AMP and epinephrine. Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 2 Topics: Adrenergic alpha-Antagonists; Animals; Bucladesine; Chloroquine; Doxazosin; Epinephrine; Epoxy Compounds; Fatty Acids; Lipid Mobilization; Liver; Male; Prazosin; Propranolol; Rats; Triglycerides	1989
Cationic amphiphilic drugs perturb the metabolism of inosititides and phosphatidic acid in photoreceptor membranes. Biochemical and biophysical research communications, 1986, Jan-14, Volume: 134, Issue:1 Topics: Acetamides; Adenosine Triphosphate; Animals; Brain; Calcium; Cattle; Chloroquine; Dose-Response Relationship, Drug; Lidocaine; Light; Magnesium; Phosphatidic Acids; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Phosphatidylinositols; Phosphoinositide Phospholipase C; Phosphoric Diester Hydrolases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Photoreceptor Cells; Procaine; Propranolol; Rats; Retina; Rod Cell Outer Segment; Tetracaine	1986
Selective lysosomal uptake and accumulation of the beta-adrenergic antagonist propranolol in cultured and isolated cell systems. Biochemical pharmacology, 1986, Apr-15, Volume: 35, Issue:8 Topics: Animals; Cells, Cultured; Chloroquine; Dogs; Epithelium; HeLa Cells; Humans; Hydrogen-Ion Concentration; Lysosomes; Mice; Muscle, Smooth; Myocardium; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism	1986
Receptor-independent sequestration of beta-adrenergic ligands by alveolar type II cells. The American journal of physiology, 1986, Volume: 250, Issue:6 Pt 1 Topics: Animals; Cell Membrane; Cells, Cultured; Chloroquine; Hydrogen-Ion Concentration; Iodine Radioisotopes; Iodocyanopindolol; Lung; Male; Pindolol; Propranolol; Pulmonary Alveoli; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta	1986
Myoblast fusion is regulated by a prostanoid of the one series independently of a rise in cyclic AMP. The Journal of cell biology, 1986, Volume: 103, Issue:3 Topics: Alprostadil; Animals; Arachidonic Acid; Arachidonic Acids; Cell Fusion; Cells, Cultured; Chick Embryo; Chloroquine; Cyclic AMP; Dinoprostone; Eicosanoic Acids; Indomethacin; Isoproterenol; Muscles; Propranolol; Prostaglandins E	1986
Types of interaction of amphiphilic drugs with phospholipid vesicles. The Journal of pharmacology and experimental therapeutics, 1988, Volume: 246, Issue:1 Topics: Amiodarone; Anilino Naphthalenesulfonates; Binding Sites; Chloramphenicol; Chloroquine; Chlorpromazine; Diphenylhexatriene; Imipramine; Lipidoses; Lung Diseases; Membrane Lipids; Phospholipids; Promethazine; Propranolol; Surface-Active Agents; Trimipramine	1988
Cationic amphiphilic drugs inhibit the synthesis of long-chain fatty acyl coenzyme A in rat brain microsomes. FEBS letters, 1985, Mar-11, Volume: 182, Issue:1 Topics: Acyl Coenzyme A; Anesthetics, Local; Animals; Brain; Chloroquine; Lidocaine; Microsomes; Propranolol; Rats; Tetracaine	1985
Mechanism of cationic amphiphilic drug inhibition of purified lysosomal phospholipase A1. Biochemistry, 1985, Nov-05, Volume: 24, Issue:23 Topics: Animals; Chloroquine; Chlorpromazine; Kinetics; Liposomes; Liver; Lysosomes; Male; Mathematics; Phosphatidylcholines; Phospholipases; Phospholipases A; Phospholipases A1; Propranolol; Protein Binding; Rats; Rats, Inbred Strains	1985
Effects of antilipolytic drugs on cyclic 3',5'-AMP dependent protein kinase. Naunyn-Schmiedeberg's archives of pharmacology, 1973, Volume: 278, Issue:3 Topics: Adipose Tissue; Animals; Cattle; Chloroquine; Cyclic AMP; Dose-Response Relationship, Drug; Flufenamic Acid; In Vitro Techniques; Insulin; Lipid Metabolism; Mefenamic Acid; Muscles; Nicotinic Acids; Norepinephrine; Phentolamine; Phenylbutazone; Phosphotransferases; Propranolol; Prostaglandins; Protein Kinase Inhibitors; Protein Kinases; Pyrazoles; Theophylline	1973
Neutrophilic leukocytes in immunologic reactions in vitro. 3. Pharmacologic modulation of lysosomal constituent release. Clinical immunology and immunopathology, 1974, Volume: 2, Issue:2 Topics: Animals; Bucladesine; Chloroquine; Colchicine; Collagen; Epinephrine; Ethylmaleimide; Exocytosis; Ferritins; Glucose; Hydrocortisone; Iodoacetates; Isoproterenol; Latex; Lysosomes; Membranes; Microspheres; Models, Biological; Neutrophils; Phagocytosis; Phenylephrine; Propranolol; Rabbits; Salicylates; Theophylline; Vinblastine	1974
Effect of chloroquine phosphate on the isolated non-pregnant and pregnant uterus of different species. Acta physiologica Academiae Scientiarum Hungaricae, 1974, Volume: 45, Issue:1-2 Topics: Acetylcholine; Animals; Atropine; Chloroquine; Dinitrophenols; Female; Guinea Pigs; In Vitro Techniques; Lysergic Acid Diethylamide; Oxytocin; Phenoxybenzamine; Pregnancy; Propranolol; Rabbits; Rats; Species Specificity; Tetracaine; Time Factors; Uterine Contraction; Uterus	1974
[Prevention of stress disorders of myocardial contractile function using membrane protectors]. Kardiologiia, 1983, Volume: 23, Issue:7 Topics: Animals; Calcium; Chloroquine; Fatty Acids; Humans; Lipase; Myocardial Contraction; Myocardium; Niacinamide; Oxygen; Phospholipases; Propranolol; Rats; Rats, Inbred Strains; Stress Disorders, Post-Traumatic	1983
The effects of chloroquine on the electrocardiogram and heart rate in anaesthetized dogs. Clinical physiology (Oxford, England), 1983, Volume: 3, Issue:1 Topics: Animals; Cardiac Pacing, Artificial; Chloroquine; Dogs; Electrocardiography; Epinephrine; Heart Rate; Propranolol	1983
[Long-term use of superhigh doses of drug preparations]. Terapevticheskii arkhiv, 1982, Volume: 54, Issue:11 Topics: Adult; Chloroquine; Drug Tolerance; Female; Furosemide; Humans; Male; Middle Aged; Propranolol; Self Medication; Time Factors	1982
Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. The Journal of cell biology, 1981, Volume: 90, Issue:3 Topics: Amines; Animals; Ascitic Fluid; Atropine; Chloroquine; Hydrogen-Ion Concentration; Lysosomes; Macrophages; Mice; Organoids; Osmosis; Propranolol; Vacuoles	1981
Loss of red blood cell glutathione during Mg deficiency: prevention by vitamin E, D-propranolol, and chloroquine. The American journal of physiology, 1994, Volume: 267, Issue:5 Pt 1 Topics: Animals; Chloroquine; Erythrocytes; Glutathione; Magnesium Deficiency; Male; Propranolol; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances; Time Factors; Vitamin E	1994
Tyrosine phosphorylation in psoriatic T cells is modulated by drugs that induce or improve psoriasis. Dermatology (Basel, Switzerland), 1995, Volume: 191, Issue:3 Topics: Adolescent; Adult; Aged; Case-Control Studies; Cells, Cultured; Chloroquine; Cyclosporine; Ethanol; Female; Humans; Immunosuppressive Agents; Irritants; Lithium; Lymphocyte Activation; Male; Middle Aged; Phosphorylation; Phytohemagglutinins; Propranolol; Protein-Tyrosine Kinases; Psoriasis; T-Lymphocytes; Tacrolimus; Time Factors; Tyrosine	1995
Inhibition of blood platelet functions by cationic amphiphilic drugs in relation to their physico-chemical properties. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1996, Volume: 7, Issue:2 Topics: Animals; Benzothiepins; Blood Platelets; Chemical Phenomena; Chemistry, Physical; Chloroquine; Diphenhydramine; Dose-Response Relationship, Drug; Platelet Aggregation Inhibitors; Platelet Function Tests; Propranolol; Radioimmunoassay; Rats; Software; Structure-Activity Relationship; Thrombin; Thromboxane B2	1996
Chloroquine inhibits alpha1B-adrenergic action in hepatocytes. European journal of pharmacology, 1998, Jan-26, Volume: 342, Issue:2-3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Cell Membrane; Chloroquine; Liver; Male; Norepinephrine; Phosphatidylinositols; Phosphorylase a; Propranolol; Protein Kinase C; Protein Kinases; Rats; Rats, Wistar	1998
Cationic amphiphilic drugs and platelet phospholipase A(2) (cPLA(2)). Thrombosis research, 2002, Feb-15, Volume: 105, Issue:4 Topics: Alprenolol; Animals; Arachidonic Acid; Benzothiepins; Blood Platelets; Chloroquine; Diphenhydramine; Enzyme Activation; In Vitro Techniques; Male; Metipranolol; Phospholipases A; Phospholipases A2; Platelet Aggregation; Platelet Aggregation Inhibitors; Propranolol; Rats; Rats, Wistar; Surface-Active Agents	2002
[Effects of drugs known to trigger psoriasis on HaCaT keratinocytes]. Yao xue xue bao = Acta pharmaceutica Sinica, 2007, Volume: 42, Issue:10 Topics: Adrenergic beta-Antagonists; Antimalarials; Cells, Cultured; Chloroquine; Humans; Interleukin-6; Interleukin-8; Keratinocytes; Lithium Carbonate; Propranolol; Psoriasis; RNA, Messenger; Tumor Necrosis Factor-alpha	2007
Melanin targeting for intracellular drug delivery: Quantification of bound and free drug in retinal pigment epithelial cells. Journal of controlled release : official journal of the Controlled Release Society, 2018, 08-10, Volume: 283 Topics: Animals; Biological Transport; Cell Line; Chloroquine; Diclofenac; Epithelial Cells; Humans; Melanins; Methotrexate; Molecular Targeted Therapy; Propranolol; Retinal Pigment Epithelium; Swine; Timolol	2018
Characterization of artificially re-pigmented ARPE-19 retinal pigment epithelial cell model. Scientific reports, 2019, 09-24, Volume: 9, Issue:1 Topics: Animals; Biological Transport; Cell Line; Chloroquine; Diclofenac; Humans; Melanins; Melanosomes; Methotrexate; Phagocytosis; Pigmentation; Propranolol; Retina; Retinal Pigment Epithelium; Retinal Pigments; Swine	2019
Potential effect of chloroquine and propranolol combination to treat colorectal and triple-negative breast cancers. Scientific reports, 2023, 05-16, Volume: 13, Issue:1 Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chloroquine; Colorectal Neoplasms; Humans; Mice; Propranolol; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays	2023
Adsorption of chloroquine, propranolol, and metformin in aqueous solutions using magnetic graphene oxide nanocomposite. Environmental science and pollution research international, 2023, Volume: 30, Issue:36 Topics: Adsorption; Chloroquine; Graphite; Hydrogen-Ion Concentration; Kinetics; Magnetic Phenomena; Metformin; Nanocomposites; Pharmaceutical Preparations; Propranolol; Water; Water Pollutants, Chemical	2023